Clinical Trial Update: Does a Nasal Instillation of Miglustat Normalize the Nasal Potential Difference in Cystic Fibrosis Patients ? [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating nasal instillation of miglustat to normalize nasal potential difference in cystic fibrosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Miglustat (Zavesca) (Miglustat)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED